How We Work

Our day-to-day mission is to unleash the extraordinary potential of French cancer research by providing financial, strategic, and human support. Here's how we make it happen.

391 million Since 2012, we have allocated over €391 million to our charitable activities, including more than €346 million dedicated specifically to cancer research.  

Earning Your Trust

100% of ARC Foundation's income comes from the generosity of the public. On behalf of patients, donors, researchers, and our partners, ARC Foundation is committed every day to the rigorous and transparent management of the funds entrusted to us. Every euro we receive is a precious resource, used efficiently to fund research projects and improve patient care. 

To find out more about the Fondation ARC's Conflict of Interest Prevention and Management Policy 

Where Your Money Goes ?

See how public donations were allocated in 2024.  

  • The proportion of our expenditure allocated to the social mission  : 76,2 % 
  • The share allocated tox Fundraising costs : 17,2 % 
  • The share of the costs Internal workings and other charges : 6,6 %

 

What Our Charitable Spending Funds

Expenditure on ourcharitableactivities (research  support and health information) goes towards 

  • €33.2 million invested in funding Innovative research projects and supportingresearchers, 
  • €3.8 million For the development of scientific and  medical information programmes

In 2024, ARC Foundation allocated 76.2% of its expenditure to charitable activities more than €39 million. 

 

Following Your Donation

From collection to allocation to a research project, every donation follows a rigorous process. 

1. Collection

ARC Foundation receives donations and legacies from the general public and our partners. 

 2. Selection 

Through a scientific evaluation process led by volunteer cancerresearch experts, ARC Foundationselects the research projects to fund. 

 3. Monitoring 

ARC Foundation monitors and supports the research projects it funds to guarantee and maximise the impact of allocated donations. 

 4. Communication 

The ARC Foundation communicates the results of funded research projects to enable everyone to: 

  • measure progress 
  • Understanding the major challenges of research 
When you donate, research takes a leap forward.
I help, I give

Why Give ?

The important question: How does ARC Foundation ensure donations and legacies are used properly? 

Through external audits and annual certification by independent auditors. Furthermore, ARC Foundation has been a member of the Comité de la Charte du Don en Confiance (the French Responsible Giving Charter Committee) since 1999. This accreditation, awarded by a non-profit organisation, is an essential guarantee in France for safeguarding donors' and legacy donors' contributions. Since that date, the Foundation has successfully renewed its accreditation every year. 

Learn more about our accreditation 

For Today or Tomorrow?

ARC Foundation researchers present the discoveries and innovations that are pushing back the boundaries of cancer treatment.

When you donate, research takes a leap forward.
And you may be eligible for tax relief of up to 66% or 75% of your donation value.
Support US - Donate

Why Give ?

Meet Our Researchers

Who are they? What do they do? What areas of research do they work in? Through a questionnaire in ARC Foundation's signature colours, our researchers share insights into their work.
  • Researcher Marc Billaud

    BLUE LIKE THE HORIZON OF RESEARCH if we agree to give a central place to prevention, which must be at the heart of health policies in oncology

    Marcbillaud
  • Prof. Karin Tarte

    Yellow like the optimism that bold researchers inspire when looking into the so-called grey areas of cancer research.

    Karine Tarte Photographer Researcher Blue Arc Foundation Smile
  • Dr Julie Caramel and Professor Stéphane Dalle

    Blue like the horizon of research if it continues to be enriched by fruitful interactions between doctors and researchers.

    Photo of researchers Dalle and Caramel for the ARC Foundation
  • Prof. Hélène Péré

    Blue as the horizon of research if we manage to predict the risk of relapse thanks to viral biomarkers and circulating tumour DNA.

    Photo of researcher Hélène Péré for the ARC Foundation